Author: GlobeNewswire

SAN FRANCISCO, Oct. 21, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a…

Management to host conference call today at 5:00 p.m. ETAUSTIN, Texas, Oct. 21, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc.…

CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for…

REDWOOD CITY, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise…

Expands International Commercialization with Initial Shipment of T2Dx Instruments to AsiaLEXINGTON, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — T2 Biosystems,…

SANTA MONICA, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines…

Special Committee of the Board of Directors has concluded its investigation of Dr. Leen Kawas’s Doctoral ResearchConference call to be…

REDWOOD CITY, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) — PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on…

STOUGHTON, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being…

CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular…